ROSS J. GRIGSBY Ph.D.
**** **** ***. ** *** Brighton, M N 55112
*********@*****.*** 612-***-****
Summary of Qualifications
Focused, results-driven Scientist with over three years of experience in pre-clinical and
●
clinical pharmaceutical drug delivery research.
Extensive knowledge of pharmacokinetic absorption models, formulation of peptides and
●
small molecules, designing experiments and writing reports.
Proven research group leader, consistently meeting the most challenging organizational
●
goals while producing high performance standards and quality results.
E xtensive experience managing and supporting projects performed at contract labs.
●
Professional Experience
Nanocopoeia, St Paul, M N
Consultant 11/2012 to present
1. Developed project proposal for testing permeability of drug nanoparticle
formulations using i n vitro and animal absorption models.
2. Identified, evaluated and managed contract labs for preclinical studies.
3. Set-up cell culture lab for cell-based permeation assays.
C ima Labs, Brooklyn Par k, M N
Consultant 8/2012 to
12/2012
Scientist I 2008
t o 1/2012
4. Instrumental in pre-clinical development through Phase I clinical t r ial for
small molecules and peptides.
1. Tested formulations in pre-clinical models and identified optimal prototype
for evaluation in human.
2. Participated in the development of a clinical protocol (Phase I) for a small
t herapeutic peptide.
3. Identified, evaluated, and managed contract research organizations for
L C/MS analysis of a peptide in Phase I t r ial.
4. Coordinated study sample shipment, review of data, and dissemination of
results.
5. Served as project manager to generate experimental results in support of
patent li tigation.
1. Led internal formulations personnel for manufacturing of test article.
2. Managed contract labs (animal research lab and bioanalytical lab) under a
very tight deadline.
6. Led challenging immunoassay development projects internally and with CROs
(ELISA, MSD, Gyros).
Ross J. Grigsby
Page 1 of 3
7. In charge of all aspects of drug delivery research and pre-clinical development.
1. Generated protocols for cell culture drug permeability experiments and
animal absorption studies.
2. Trained and directed research assistants.
3. Analyzed and presented experimental results.
8. Developed cell culture permeability and animal absorption models used for
p harmacokinetic absorption studies of peptides and small molecules, specializing in oral
t ransmucosal buccal delivery.
9. Oversaw every aspect of preclinical animal studies performed at a contract lab
for testing bioavailability of peptides and small molecules using oral, buccal, and enteric
coated formulations.
1. Formulated test articles for studies.
2. Wrote protocols for and directly supervised animal testing.
3. Coordinated sample analysis with internal analytical labs and CROs.
10. Performed pre-clinical and clinical GMP manufacturing and packaging of test
a rticles.
11. Proposed and defended the laboratory budget, secured bids and contracts,
i ni tiated and reviewed confidentiality disclosure agreements, responsible for on time
delivery of supplies and equipment.
ROSS J. GRIGSBY Ph.D.
Rensselaer Polytechnic I nstitute, T roy, NY
2006-2007
Postdoctoral Research Associate
1. Using i n vitro assays and mammalian cell assays, I successfully identified
and characterized a novel drug that targets the centrosome and inhibits
cell division.
2. Proficient in numerous laboratory techniques including protein
p urification using BioRad Biologic DuoFlow FPLC, protein purification
using sucrose density ult racentr ifugation and numerous other t raditional
and modern protein purification methods, and immunofluorescent
l abeling.
University of Kansas, Law rence, KS Degree completed
M ay 2006
Graduate Research Assistant
3. Successfully identified novel centrosome proteins from Spisula
solidissima oocytes using t radition biochemical purification techniques
combined with mass spectrometry.
Ross J. Grigsby
Page 2 of 3
4. Researched signaling mechanisms in cultured adipocytes pertaining to
T ype 2 diabetes and showed a parallel pathway for TNF signaling in
adipocytes.
5. Acquired skills in mammalian and insect t issue culture procedures, SDS-
PAGE, gel staining, immunoblotting, lipid analysis through radioisotope
l abeling, G-protein column chromatography purification of monoclonal
antibodies, brightfield, polarized light, and epifluorescence microscopy.
6. Excellent presentation skills acquired through teaching undergraduate
l aboratory classes and presenting scientific results at lab meetings and
yearly conferences.
Education
• University of Kansas, Lawrence, Kansas, Ph.D., Biochemistry and Biophysics
• Iowa State University, Ames, Iowa, B.S. Physical Education, Sports Medicine
E mphases
Honors
7. Graduate Training Grant Recipient, Dynamic Aspects of Chemical
B iology, University of Kansas, supported by the National Institute of
General Medical Sciences, T32 GM08545
8. Recipient of the Kenneth B. Armitage Award for Excellence in Teaching
P rinciples of Biology Laboratory
Publications
9. Dissertation: Grigsby, R. J. Identifying gamma-tubulin r ing complex
adaptor proteins in centrosomes isolated from the surf clam, Spisula
solidissima . University of Kansas Libraries. 2006, 154 p.
10. Grigsby, R. J., Dobrowsky, R.T. Inhibition of ceramide production reverses
T NF induced insulin resistance. B iochem Biophys Res Commun . 2001 Oct
12;287(5):1121-4.
11. Bilderback T.R., Grigsby R. J., Dobrowsky, R.T. Association of p75(NTR)
w ith caveolin and localization of neurotrophin-induced sphingomyelin
hydrolysis to caveolae. J B iol Chem. 1997 Apr 18;272(16):10922-7.
Professional Affiliations
12. American Association of Pharmaceutical Scientists
Computer Skills
13. M icrosoft Word, M icrosoft Excel, M icrosoft Power Point, Metamorph,
E ndnote, SigmaPlot, Adobe Photoshop
Ross J. Grigsby
Page 3 of 3